| 14/3/2025 | 13:38 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 14/3/2025 | 13:35 | GLOBE | Polyrizon Signs Non– Binding LOI to Expand its Innovative.. |
| 13/3/2025 | 21:42 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 13/3/2025 | 12:51 | GLOBE | Polyrizon Launches Preclinical Studies for Intranasal.. |
| 11/3/2025 | 21:27 | GLOBE | Polyrizon Ltd. Files Annual Report on Form 20-F for the.. |
| 11/3/2025 | 21:23 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
| 11/3/2025 | 21:05 | EDGAR2 | Form 20-F - Annual and transition report of foreign private.. |
| 10/3/2025 | 22:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 10/3/2025 | 12:47 | GLOBE | Polyrizon Initiates Preclinical Studies for Intranasal.. |
| 05/3/2025 | 22:00 | EDGAR2 | Form SCHEDULE 13G - Statement of Beneficial Ownership by.. |
| 30/1/2025 | 12:06 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 30/1/2025 | 11:55 | GLOBE | Polyrizon Announces Filing of Divisional Patent Application.. |
| 23/1/2025 | 14:59 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 23/1/2025 | 12:40 | GLOBE | Polyrizon Commences GMP Manufacturing Preliminary Process.. |
| 22/1/2025 | 22:15 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 21/1/2025 | 22:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 10/1/2025 | 22:16 | EDGAR2 | Form F-1/A - Registration statement for certain foreign.. |
| 30/12/2024 | 22:52 | EDGAR2 | Form F-1 - Registration statement for certain foreign.. |
| 30/12/2024 | 12:29 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 30/12/2024 | 12:25 | GLOBE | Polyrizon Announces Publication of U.S. National Patent.. |
| 19/12/2024 | 14:21 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 19/12/2024 | 13:22 | GLOBE | Polyrizon Appoints Dr. Michal Meir as Senior Director of.. |
| 18/12/2024 | 12:25 | GLOBE | Polyrizon's Moving Forward with Expected 2025 Clinical Trial.. |
| 13/12/2024 | 22:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 13/12/2024 | 12:25 | GLOBE | Polyrizon Announces Appointment of VP of Regulatory Affairs.. |
| 02/12/2024 | 22:01 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 02/12/2024 | 14:02 | GLOBE | Polyrizon Enters into GMP Manufacturing Agreement for CTM.. |
| 30/10/2024 | 21:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 30/10/2024 | 15:28 | GLOBE | Polyrizon Announces Closing of $4.2 Million Initial Public.. |
| 30/10/2024 | 13:33 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 30/10/2024 | 13:31 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 29/10/2024 | 00:02 | GLOBE | Polyrizon Announces Pricing of $4.2 Million Initial Public.. |
Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
